Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock Post author:Sam Post published:May 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Pharma Bro Manages to Elect Five Pals to Turing's Board Before Trial June 26, 2017 Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim November 1, 2017 Biotech Loses a Legend: Founder and Longtime CEO Dies at 71 May 14, 2017